In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

High Risk Medicines Survey 2022/23

Prevalence of high risk medicines use
 
During 2022/23 there is a
 
Monthly requirement to submit data on: 
 
  1. The number of patients whose prescriptions were dispensed where all of the following conditions are met: 
 
  • Dispensed a prescription for sodium valproate or valproic acid 
  • Who are female 
  • Aged between 13 and 50 
 
  1. Of the number identified in 1. The number who participate in the Valproate Pregnancy Prevention Programme 
 
Quarterly requirement to submit data on: 
 
  1. The number of patients whose prescriptions were dispensed where all of the following conditions are met: 
 
  • Dispensed a prescription for an antipsychotic drug as specified in section 3.6 “psychoses and schizophrenia” of Chapter 4 of the BNF 
 
  • Aged 65 or over 
  1. Of the number identified in 3. The number who are resident in a care home. 
 
The schedule for data collection is as follows: 
 
Indicator(s)  Period to which the data relates  Submission date on NECAF 
1,2  April 2022 May 2022
1,2  May 2022  June 2022 
1,2,3,4  June 2022  July 2022
1,2  July 2022 August 2022 
1,2  August 2022  September 2022 
1,2,3,4  September 2022  October 2022
1,2  October 2022 November 2022 
1,2  November 2022  December 2022 
1,2,3,4  December 2022  January 2023
1,2  January 2023 February 2023 
1,2  February 2023  March 2023
1,2,3,4  March 2023 April 2023
 


 
 
 
DATA COLLECTION SHEET FOR VALPROATE PRESCRIPTIONS (MONTHLY)
 
DATA COLLECTION SHEET FOR ANTIPYSCHOTIC PRESCRIPTIONS (QUARTERLY)
 
List of antipsychotic drugs as specified in section 3.6 of chapter 4 of the BNF April 2021